Omega-3 fatty acids ameliorate atherosclerosis by favorably altering monocyte subsets and limiting monocyte recruitment to aortic lesions

Arterioscler Thromb Vasc Biol. 2012 Sep;32(9):2122-30. doi: 10.1161/ATVBAHA.112.253435. Epub 2012 Jul 19.

Abstract

Objective: Fish oil, containing omega-3 fatty acids, attenuates atherosclerosis. We hypothesized that omega-3 fatty acid-enriched oils are atheroprotective through alteration of monocyte subsets and their trafficking into atherosclerotic lesions.

Methods and results: Low-density lipoprotein receptor knockout and apolipoprotein E(-/-) mice were fed diets containing 10% (calories) palm oil and 0.2% cholesterol, supplemented with an additional 10% palm oil, echium oil (containing 18:4 n-3), or fish oil. Compared with palm oil-fed low-density lipoprotein receptor knockout mice, echium oil and fish oil significantly reduced plasma cholesterol, splenic Ly6C(hi) monocytosis by ≈50%, atherosclerosis by 40% to 70%, monocyte trafficking into the aortic root by ≈50%, and atherosclerotic lesion macrophage content by 30% to 44%. In contrast, atherosclerosis and monocyte trafficking into the artery wall was not altered by omega-3 fatty acids in apolipoprotein E(-/-) mice; however, Ly6C(hi) splenic monocytes positively correlated with aortic root intimal area across all diet groups. In apolipoprotein E(-/-) mice, fish oil reduced the percentage of blood Ly6C(hi) monocytes, despite an average 2-fold higher plasma cholesterol relative to palm oil.

Conclusions: The presence of splenic Ly6C(hi) monocytes parallels the appearance of atherosclerotic disease in both low-density lipoprotein receptor knockout and apolipoprotein E(-/-) mice. Furthermore, omega-3 fatty acids favorably alter monocyte subsets independently from effects on plasma cholesterol and reduce monocyte recruitment into atherosclerotic lesions.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antigens, Ly / blood
  • Aorta / drug effects*
  • Aorta / immunology
  • Aorta / metabolism
  • Aorta / pathology
  • Aortic Diseases / blood
  • Aortic Diseases / genetics
  • Aortic Diseases / immunology
  • Aortic Diseases / pathology
  • Aortic Diseases / prevention & control*
  • Apolipoproteins E / deficiency
  • Apolipoproteins E / genetics
  • Atherosclerosis / blood
  • Atherosclerosis / genetics
  • Atherosclerosis / immunology
  • Atherosclerosis / pathology
  • Atherosclerosis / prevention & control*
  • Biomarkers / blood
  • Chemotaxis / drug effects*
  • Cholesterol, Dietary / blood
  • Dietary Supplements*
  • Disease Models, Animal
  • Echium
  • Fatty Acids, Omega-3 / pharmacology*
  • Female
  • Inflammation Mediators / blood
  • Macrophages / drug effects
  • Macrophages / immunology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Monocytes / drug effects*
  • Monocytes / immunology
  • Monocytes / metabolism
  • Monocytes / pathology
  • Neutrophils / drug effects
  • Neutrophils / immunology
  • Palm Oil
  • Plant Oils / pharmacology*
  • Receptors, LDL / deficiency
  • Receptors, LDL / genetics
  • Spleen / drug effects*
  • Spleen / immunology
  • Spleen / metabolism
  • Time Factors

Substances

  • Antigens, Ly
  • Apolipoproteins E
  • Biomarkers
  • Cholesterol, Dietary
  • Fatty Acids, Omega-3
  • Inflammation Mediators
  • Ly-6C antigen, mouse
  • Plant Oils
  • Receptors, LDL
  • Palm Oil